Citation: Hanne Trap Wolf, Hanne Kristine Hegaard, Anja Bisgaard Pinborg, Lene Drasbek Huusom. Does Antenatal Administration of Magnesium Sulphate Prevent Cerebral Palsy and Mortality in Preterm Infants? A Study Protocol.[J]. AIMS Public Health, 2015, 3(4): 727-729. doi: 10.3934/publichealth.2015.4.727
| [1] | Himpens E, Van den Broeck C, Oostra A et al. Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review. Dev Med Child Neurol. May 2008;50(5):334-40. |
| [2] | Wolf HT, Hegaard HK, Greisen G et al. Treatment with magnesium sulphate in pre-term birth: a systematic review and meta-analysis of observational studies. J Obstet Gynaecol J Inst Obstet Gynaecol. February 2012;32(2):135-40. |
| [3] | Doyle LW, Crowther CA, Middleton P et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009;(1):CD004661. |
| [4] | Huusom LD, Secher NJ, Pryds O et al. Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants-but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis. BJOG Int J Obstet Gynaecol. January 2011;118(1):1-5. |
| [5] | Schonhaut L, Armijo I, Schönstedt M et al. Validity of the ages and stages questionnaires in term and preterm infants. Pediatrics. May 2013;131(5):e1468-1474. |
Hanne Trap Wolf, Hanne Kristine Hegaard, Anja Bisgaard Pinborg, Lene Drasbek Huusom. Does Antenatal Administration of Magnesium Sulphate Prevent Cerebral Palsy and Mortality in Preterm Infants? A Study Protocol.[J]. AIMS Public Health, 2015, 3(4): 727-729. doi: 10.3934/publichealth.2015.4.727
DownLoad: